Skip to main content
. 2022 Oct 13;12:17187. doi: 10.1038/s41598-022-22104-4

Table 4.

Comparison of successful and unsuccessful groups (N = 31).

Successful group (N = 21) Unsuccessful group (N = 10) P-value
Age at baseline (years) 74.2 ± 9.4 72.1 ± 9.5 0.56
Sex (female/male), no 5/16 4/6 0.42a
Axial length (mm) 24.44 ± 1.45 25.11 ± 1.92 0.29
Central corneal thickness (μm) 520.0 ± 33.4 530.1 ± 47.9 0.50
Visual field mean deviation (dB) − 9.74 ± 6.95 − 9.80 ± 3.90 0.98
Single/combined with cataract surgery, no 10/11 4/6  > 0.99a
Surgical procedure (microhook/TOM/s-LOT) 6/3/12 3/5/2 0.067a
Preoperative anti-glaucoma eye drops, no 3.6 ± 0.9 4.2 ± 0.6 0.063
Preoperative IOP (mmHg) 24.3 ± 7.5 21.6 ± 6.0 0.33
Anti-glaucoma eye drops 1 year after surgery, no 1.4 ± 1.2 3.4 ± 0.9  < 0.001
IOP 1 year after surgery (mmHg) 13.9 ± 3.1 19.6 ± 4.2  < 0.001
IOP change rate 1 year after surgery (%) − 39.8 ± 14.5 − 3.4 ± 23.3  < 0.001
Preoperative superficial VD (%) 27.13 ± 7.59 26.44 ± 7.59 0.82
Postoperative superficial VD (%) 27.12 ± 6.72 28.43 ± 8.06 0.64
Preoperative deep VD (%) 10.20 ± 4.18 15.71 ± 9.63 0.11
Postoperative deep VD (%) 8.95 ± 2.76 13.52 ± 7.14 0.078

Data are presented as the mean ± standard deviation unless otherwise indicated.

IOP, intraocular pressure; s-LOT, suture trabeculotomy; TOM, Trabectome; VD, vessel density.

P-value: aCalculated using Fisher's exact test; The other values were calculated using an unpaired t-test.

Significant values are in bold.